1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Amrubicin (Japan only): new trials by email Literature Review of Amrubicin (Japan only) trials Research Report on Amrubicin (Japan only)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer Sacituzumab Govitecan (SG), Topotecan, Amrubicin (Japan only) - Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 3 | Recruiting | Gilead Sciences | 695 | 2025-04-04 | 2026-10-20 |
Gilead Sciences (1)
Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1) · Malaysia (1) · Netherlands (1)